Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Shanghai No.1 Pharmacy Co.,Ltd. (600833.SS)

Compare
11.96
-0.21
(-1.73%)
At close: April 11 at 3:00:04 PM GMT+8
Loading Chart for 600833.SS
  • Previous Close 12.17
  • Open 12.12
  • Bid 11.94 x --
  • Ask 11.96 x --
  • Day's Range 11.93 - 12.19
  • 52 Week Range 10.21 - 17.66
  • Volume 4,874,900
  • Avg. Volume 5,201,786
  • Market Cap (intraday) 2.668B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) 16.38
  • EPS (TTM) 0.73
  • Earnings Date --
  • Forward Dividend & Yield 0.13 (0.98%)
  • Ex-Dividend Date Jun 21, 2024
  • 1y Target Est --

Shanghai No.1 Pharmacy Co.,Ltd., together with its subsidiaries, engages in the retail and wholesale of pharmaceutical products in China. The company also sells food, medical equipment, health convenience products, and other commodities. It serves terminal medicinal institutions and pharmaceutical companies. Shanghai No. 1 Pharmacy Co.,Ltd. was founded in 1992 and is headquartered in Shanghai, China.

www.shdyyy.com.cn

870

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 600833.SS

View More

Performance Overview: 600833.SS

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

600833.SS
11.41%
SSE Composite Index (000001.SS)
3.39%

1-Year Return

600833.SS
9.21%
SSE Composite Index (000001.SS)
6.72%

3-Year Return

600833.SS
4.82%
SSE Composite Index (000001.SS)
2.24%

5-Year Return

600833.SS
35.73%
SSE Composite Index (000001.SS)
15.79%

Compare To: 600833.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 600833.SS

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    2.67B

  • Enterprise Value

    2.49B

  • Trailing P/E

    16.38

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.39

  • Price/Book (mrq)

    2.35

  • Enterprise Value/Revenue

    1.30

  • Enterprise Value/EBITDA

    8.65

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.67%

  • Return on Assets (ttm)

    -0.79%

  • Return on Equity (ttm)

    16.78%

  • Revenue (ttm)

    1.85B

  • Net Income Avi to Common (ttm)

    179.1M

  • Diluted EPS (ttm)

    0.73

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    406.56M

  • Total Debt/Equity (mrq)

    22.34%

  • Levered Free Cash Flow (ttm)

    -235.52M

Research Analysis: 600833.SS

View More

Company Insights: 600833.SS

Research Reports: 600833.SS

View More

People Also Watch